KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Co-Diagnostics (CODX) Other Non Operating Income (2017 - 2020)

Historic Other Non Operating Income for Co-Diagnostics (CODX) over the last 4 years, with Q3 2020 value amounting to $778549.0.

  • Co-Diagnostics' Other Non Operating Income rose 89704.85% to $778549.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $980429.0, marking a year-over-year increase of 41112.29%. This contributed to the annual value of -$301816.0 for FY2019, which is 9610.28% down from last year.
  • According to the latest figures from Q3 2020, Co-Diagnostics' Other Non Operating Income is $778549.0, which was up 89704.85% from $296732.0 recorded in Q2 2020.
  • In the past 5 years, Co-Diagnostics' Other Non Operating Income registered a high of $778549.0 during Q3 2020, and its lowest value of -$2.1 million during Q3 2017.
  • In the last 4 years, Co-Diagnostics' Other Non Operating Income had a median value of -$32802.0 in 2018 and averaged -$95736.7.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 53174.95% in 2019, then soared by 128867.47% in 2020.
  • Over the past 4 years, Co-Diagnostics' Other Non Operating Income (Quarter) stood at $311514.0 in 2017, then crashed by 140.1% to -$124918.0 in 2018, then increased by 10.65% to -$111608.0 in 2019, then soared by 797.57% to $778549.0 in 2020.
  • Its Other Non Operating Income stands at $778549.0 for Q3 2020, versus $296732.0 for Q2 2020 and $16756.0 for Q1 2020.